Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AGRD1 | Q6QNK2 | Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Receptor-signaling mediation | 3 | 0.53 | |||
| AGRL2 | O95490 | Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1) | 7 | Receptor-signaling mediation | 3 | 0.53 | ||||
| CAC1I | Q9P0X4 | Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3) | 24 | Fusion and delivery mediation | 3 | 0.53 | ||||
| CADM1 | Q9BY67 | Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1) | Human disease related genesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 3 | 0.53 | |||
| CCR2 | P41597 | C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192) | CD markersG-protein coupled receptorsHuman disease related genes | 7 | Alzheimer diseaseArterial occlusive diseaseChronic kidney disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| CD3E | P07766 | T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e) | CD markersDisease related genesFDA approved drug targets | 1 | Breast cancerMelanomaMycosis fungoides | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| CKLF4 | Q8IZR5 | CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4) | Predicted membrane proteinsTransporters | 4 | Other mediation | 3 | 0.53 | |||
| CLCN5 | P51795 | H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5) | Disease related genesHuman disease related genesPlasma proteins | 10 | Clinical-translation mediationFusion and delivery mediation | 3 | 0.53 | |||
| CLD19 | Q8N6F1 | Claudin-19 | 4 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.53 | ||||
| CML1 | Q99788 | Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ) | G-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Immune mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.53 |